Glaxosmithkline | GSK - 应收帐款人

金融业

GBP

GBP 62.87B

现金及等价物

GBP 3.44B

GBP 1.88B

GBP 17.76B

GBP 22.43B

GBP 19.06B

股息收益率

GBP 4.47

GBP 2.31B

GBP 2.77B

GBP 69.4K

EPS每股收益

GBP 0.62

股本和储备

GBP 17.42B

GBP 5.75B

债务利息支出

GBP 192.73M

GBP 22M

GBP 18.53B

GBP 111.21B

GBP 1.74B

GBP 5.34B

GBP 2.29B

普通股股本

GBP 4.05B

15.09

GBP 2.14B

GBP 10.09B

销售和管理费用

GBP 2.12B

GBP 6.16B

贸易债权人

GBP 14.34B

应收帐款人

GBP 10.49B

	应收帐款人	更改		日
AbbVie	USD 12.59B		180M	2025-12
Amgen	USD 9.14B		432M	2026-03
AstraZeneca	USD 17.88B		1.17B	2026-03
Aurora Cannabis	CAD 44.58M		3.68M	2026-03
Bausch Health Companies	USD 2.19B		160M	2026-03
Bristol-Myers Squibb	USD 14.36B		164M	2026-03
Canopy Growth	CAD 36.29M		104.13M	2026-03
Corcept Therapeutics	USD 39.07M		20.71M	2026-03
Drreddys Laboratories	INR 123.17B		121.76B	2026-03
Eli Lilly	USD 21.18B		1.02B	2026-03
GlaxoSmithKline	GBP 7.94B		178M	2026-03
Glaxosmithkline	GBP 10.49B		40.6M	2026-03
J&J	USD 21.33B		3.72B	2025-12
Merck	USD 11.78B		345M	2025-12
Novartis	USD 9.6B		2.69B	2026-03
Pacira	USD 125.64M		1.57M	2026-03
Perrigo	USD 697.1M		84.3M	2026-03
Pfizer	USD 16.17B		332M	2026-03
Phibro Animal Health	USD 215.87M		2.02M	2025-12
Prestige Brands	USD 191.92M		1.46M	2026-03
Roche Holding	CHF 11.9B		460M	2025-12
Sanofi	EUR 482M		85M	2026-03
Supernus Pharmaceuticals	USD 182.18M		5.62M	2026-03
Takeda	JPY 876.35B		118.43B	2026-03
Teva Pharmaceutical Industries	USD 3.39B		316M	2026-03
Zoetis	USD 1.51B		84M	2026-03